Banner Health Selects RxREVU for Prescription Decision Support
May 16, 2016
Denver, CO – Banner Health, a leading health system in the country for clinical quality, has selected RxREVU to provide enhanced prescription decision support. Nonprofit Banner Health is headquartered in Phoenix, Arizona, and operates 29 hospitals, including three academic medical centers. RxREVU delivers next generation prescription decision support at the point of care to help large health systems reduce costs and improve outcomes. By providing physicians better data at the point of care, including patient cost, adherence, and efficacy analytics, along with less expensive therapeutic alternatives and hard-wired payer clinical protocols, RxREVU offers more informed and consistent prescribing to health systems struggling to contains costs.
“Banner Health is a marquee name in clinical quality, and we are excited to bring our prescription decision support technology to their network. By providing the right information to the right person at the right time, Banner physicians will be in a better position to reduce costs and improve outcomes,” commented Carm Huntress, RxREVU Chief Executive Officer. “We empower health systems to deliver critical prescription drug information to the point of care, where it’s needed most. We believe our deployment at Banner has the potential to save a significant amount of over the next few years.”
With nearly 300,000 members currently served by the Banner Health Network, a part of Banner Health, the system has consistently demonstrated the ability to effectively manage the health and wellness of populations of insured members in both government and private plans. But with rising prescription drug costs threatening the bottom lines of nearly every delivery network in the country, Banner Health has opted to address this trend using RxREVU’s prescription decision support solution.
“We are impressed by RxREVU’s prescription decision support, and will be deploying their solution to improve outcomes and lower costs,” remarked Pam Nenaber, CEO Pharmaceutical Operations, Banner Health.